well as clinical areas such as correct insulin use in glycemic control, community-acquired pneumonia, delirium, alcohol withdrawal and falls prevention. ... Thunder. In addition to the individual efforts, which have included initiatives like nurse-led
17. The results contrast with a recent study finding significantly better survival and similar costs among “marginal” pneumonia patients admitted to the ICU instead of the general ward, the authors noted. ... The difference between the studies might
Last month's column discussed the clinical indicators of inpatient medical necessity for patients with pneumonia and cardiac arrhythmia.
Treating community-acquired pneumonia (CAP) with only 5 days of antibiotics resulted in similar success rates as allowing physicians to determine the duration of antibiotics, a new study found. ... The study excluded ICU patients, although about 40% of
31, 2013, of 580 patients from 6 Swiss acute care hospitals who had moderately severe community-acquired pneumonia (CAP). ... There were no differences between patient groups in mortality, ICU admission, complications, length of stay, and recurrence of
Any damage to the lungs, you're sort of predisposed to bad pneumonias,” he said. ... If they're treating a case of pneumonia and it's not responding to standard therapy, they should start thinking of fungal pneumonias like histoplasmosis and
The presence of a pleural effusion should be investigated in all patients who have signs and symptoms of pneumonia or unexplained sepsis, according to the American Association for Thoracic Surgery. ... Community- or health care-associated pneumonia that
The percentages of patients with pneumonia, gastrointestinal infection (including and mostly comprising C. ... Pneumonia, gastrointestinal infections, and surgical-site infections were the most common health care-associated infections.
The researchers used logistic regression models to determine the association between screening status and pneumonia rate. ... Heightened vigilance in those who fail screening could help with identifying and treating pneumonia, the authors said.
Omadacycline, a new-generation tetracycline, was approved in 2018 by the FDA to treat adults with acute bacterial skin and skin-structure infections and community-acquired bacterial pneumonia. ... ABSSI) and community-acquired bacterial pneumonia (CABP).